Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $99.99 | 1 | 76.7% |
| Food and Beverage | $30.31 | 2 | 23.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $99.99 | 1 | $0 (2017) |
| AbbVie Inc. | $29.31 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $29.31 | 1 | AbbVie Inc. ($29.31) |
| 2017 | $100.99 | 2 | Janssen Biotech, Inc. ($99.99) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/10/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $29.31 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2017 | PruGen, Inc. Pharmaceuticals | — | Food and Beverage | Cash or cash equivalent | $1.00 | General |
| 06/27/2017 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 2,914 | 7,531 | $280,459 | $177,830 |
| 2022 | 15 | 3,035 | 7,461 | $297,479 | $194,008 |
| 2021 | 17 | 3,034 | 7,711 | $285,526 | $188,959 |
| 2020 | 15 | 2,982 | 7,853 | $266,661 | $171,619 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 647 | 895 | $58,991 | $34,533 | 58.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 641 | 844 | $46,592 | $28,487 | 61.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 575 | 4,534 | $30,398 | $20,357 | 67.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 275 | 327 | $28,825 | $18,505 | 64.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 102 | 156 | $26,781 | $17,476 | 65.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 234 | 280 | $27,962 | $17,123 | 61.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 166 | 183 | $20,301 | $13,436 | 66.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 103 | $12,850 | $8,482 | 66.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 42 | 51 | $8,895 | $5,986 | 67.3% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 27 | 30 | $6,031 | $4,407 | 73.1% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 20 | 21 | $3,872 | $2,958 | 76.4% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 18 | 19 | $3,340 | $2,478 | 74.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 32 | 45 | $2,230 | $1,557 | 69.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 30 | 30 | $2,160 | $1,307 | 60.5% |
| 69100 | Biopsy of ear | Office | 2023 | 13 | 13 | $1,232 | $737.50 | 59.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 662 | 865 | $57,591 | $33,440 | 58.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 643 | 857 | $47,555 | $30,468 | 64.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 139 | 208 | $35,130 | $25,415 | 72.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 252 | 320 | $32,709 | $21,287 | 65.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 599 | 4,372 | $30,731 | $20,637 | 67.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 255 | 278 | $24,819 | $15,694 | 63.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 133 | 149 | $16,657 | $11,280 | 67.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 117 | 133 | $16,992 | $11,166 | 65.7% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2022 | 40 | 47 | $9,486 | $7,548 | 79.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 37 | 39 | $6,843 | $5,141 | 75.1% |
About Dr. Edward Mccarthy, MD
Dr. Edward Mccarthy, MD is a Dermatology healthcare provider based in Amarillo, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1902803976.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Mccarthy, MD has received a total of $130.30 in payments from pharmaceutical and medical device companies, with $29.31 received in 2021. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Education" ($99.99).
As a Medicare-enrolled provider, Mccarthy has provided services to 11,965 Medicare beneficiaries, totaling 30,556 services with total Medicare billing of $732,416. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Amarillo, TX
- Active Since 07/05/2005
- Last Updated 09/14/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1902803976
Products in Payments
- STELARA (Biological) $99.99
- HUMIRA (Biological) $29.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Amarillo
Dr. Jason Jones, M.d, M.D
Dermatology — Payments: $4,504
Scott Miller, Md, MD
Dermatology — Payments: $3,758
Christi Baker, M.d, M.D
Dermatology — Payments: $3,294
Dr. Jacques Casparian, M.d, M.D
Dermatology — Payments: $1,981
Dr. William East
Dermatology — Payments: $778.54
Dr. Tyler Enos, Md, MD
Dermatology — Payments: $348.70